Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaopi Shengji Shengyang Decoction
- Development stage
- Phase 1
- Lead developer
- Sanwa Shoyaku
- Administration
- Oral
01
Overview
Xiaopi Shengji Shengyang Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of functional dyspepsia (FD) accompanied by emaciation. The decoction is based on clinical experience and is intended to resolve epigastric distension (Xiaopi), promote tissue regeneration or weight gain (Shengji), and elevate the body's "Yang" energy (Shengyang) to improve digestive function. It is currently being evaluated in clinical trials to assess its efficacy in improving symptoms such as postprandial fullness and early satiety while addressing the nutritional status of patients.
- Other names
- 消痞生肌升阳汤
Beyond the preview
Go deeper on Xiaopi Shengji Shengyang Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaopi Shengji Shengyang Decoction.